GlaxoSmithKline Pharmaceuticals Ltd.

NSE: GLAXO | BSE: 500660 | ISIN: INE159A01016 | Industry: Pharmaceuticals
| Mid-range Performer
2532.6000 -39.00 (-1.52%)
NSE Mar 02, 2026 15:31 PM
Volume: 106.4K
 

logo
GlaxoSmithKline Pharmaceuticals Ltd.
02 Aug 2025, 12:00AM
2532.60
-1.52%
buy
by Motilal Oswal
Target: 3000 | Upside : 18.5%
Motilal Oswal
GlaxoSmithKline Pharmaceuticals (GLXO) delivered lower-than-expected revenue/EBITDA (8%/5% miss) in 1QFY26.
 
Number of FII/FPI investors decreased from 362 to 339 in Dec 2025 qtr
More from GlaxoSmithKline Pharmaceuticals Ltd.
Recommended
Bad timing: New listings sink on debut amid market turmoil
| 02 Mar 2026, 05:29PM
Market closes lower after US and Israel strike Iran, triggering risk of broader conflict
Trendlyne Marketwatch | 02 Mar 2026, 04:01PM
Five Interesting Stocks Today - February 27, 2026
The Baseline | 27 Feb 2026